Richard A. Lerner, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 7,000 shares at $15.09 ($106K) on 2017-12-11, disclosed to the SEC on 2017-12-13.
Open-market sale of $106k ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OPK | BUY | 2015-06-09 | $199K | — | Filing → |
| OPK | BUY | 2013-03-19 | $100K | — | Filing → |
| OPK | BUY | 2012-05-18 | $20K | — | Filing → |